09-18-2017 12:19 PM CET - Health & Medicine
Print

Global Biomarkers Market 2017 Overview by Key Players, Scope, Top Impacting Factors, Drivers and Restraints, Trends, Forecast (2017-2024)

Press release from: Data Bridge Market Research

"Global Biomarkers Market" - Industry Trends and Forecast to 2024


The Global Biomarkers Market is expected to reach USD 78.9 billion by 2024, from USD 31.4 billion in 2016 growing at a CAGR of 12.2% during the forecast period of 2017 to 2024.

For a Free Sample @ databridgemarketresearch.com/request-a-sample/?dbmr=globa...

The market is segmented on the basis of type, technology, application, indication, and geography.

On the basis of types, Global Biomarkers Market is segmented into consumables, services, and softwares. The consumables item is expected to represent the largest share in 2016 with the attribution of higher frequency of purchase of consumables as compared to other product segments and expanding utilization of unit based items for the testing of biomarkers.
Based on technology, the market is segmented into efficacy, safety and validation biomakers. Safety biomarkers segment represented the largest share of the global biomarkers market in 2016. It is basically used in trial phases 1 and 2, which enables as a proof of toxicity in candidate drug molecules, helps in the expansion in research and development activities and validate new candidate therapeutic products.

On the basis of application, global biomarkers market is segmented into diagnostics, drug discovery, personalized medicine and disease risk assessment. Diagnostics segment accounted the highest market share in 2016. Biomarkers assume a critical part in the treatment of different diseases. Accordingly diagnostics improvement has major biomarker application compared with different applications because of expanding healthcare expenditure, which is enhancing access to new and top notch diagnostics, and supporting development of the diagnostics application segment.

Read more about the report @ databridgemarketresearch.com/reports/global-biomarkers-ma...

Based on indication, the market is segmented into cancer, cardiovascular disorders, and immunological disorders.

Based on geography the biomarkers market is segmented into 5 major countries such as North America, South America, Europe, Asia-Pacific, and Middle East & Africa. The major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others.

Some of the major players operating in this market are
• QIAGEN
• PerkinElmer, Inc.
• Merck & Co.
• Bio-Rad Laboratories Inc.
• Enzo Biochem Inc.
• EKF Diagnostics Holdings Plc
• Abbott
• Siemens AG
• MESO SCALE DIAGOSTICS, LLC
• Agilent Technologies
• Singulex, Inc.
• Cisbio Bioassays
• Thermo Fisher Scientific Inc.
• Bruker
• Biosims Technologies
• Epigenomics AG
• Signosis, Inc.
• GE Healthcare

Inquire for TOC: databridgemarketresearch.com/toc/?dbmr=global-biomarkers-...

Table Of Content:

1.INTRODUCTION
1.1.OVERVIEW OF THE GLOBAL BIOMARKERS MARKET
1.2.MARKET SEGMENTATION & COVERAGE
1.2.1.CURRENCY AND PRICING
1.2.2.LIMITATION
1.2.3.STAKEHOLDERS
2.RESEARCH METHODOLOGY
2.1.KEY TAKEAWAYS
2.2.ARRIVING AT THE GLOBAL BIOMARKERS MARKET SIZE
2.2.1.MARKET CRACKDOWN APPROACH
2.2.2.COMPANY REVENUE AND MARKET SHARE ANALYSIS
2.2.3.DATA TRIANGULATION
2.2.4.KEY DATA POINTS FROM PRIMARY SOURCES
2.2.5.PRODUCT PIPELINE ANALYSIS
2.2.6.PORTER’S FIVE FORCES MATRIX
2.3.GLOBAL BIOMARKERS MARKET: RESEARCH SNAPSHOT
2.4.ASSUMPTIONS
3.MARKET LANDSCAPE SUMMARY
4.PREMIUM INSIGHTS
4.1.OVERVIEW
4.2.GLOBAL BIOMARKERS MARKET: KEY PRIMARY INSIGHTS
4.3.MARKET OVERVIEW
4.3.1.DRIVERS
4.3.1.1.INCREASING HEALTHCARE EXPENDITURE
4.3.1.2.NON-INVASIVE
4.3.1.3.LOW-COST FOR CONDUCTING CLINICAL TRIALS
4.3.1.4.GROWING NUMBER OF CROs
4.3.2.RESTRAINTS
4.3.3.OPPURTUNITIES
4.3.4.THREATS
4.4.KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES
5.EXECUTIVE SUMMARY
6.BIOMARKERS MARKET, BY PRODUCT TYPE
6.1.OVERVIEW
6.2.CONSUMABLES
6.3.SERVICES
6.4.SOFTWARE
7.BIOMARKERS MARKET, BY TECHNOLOGY
7.1.OVERVIEW
7.2.SAFETY BIOMARKERS
7.3.EFFICACY BIOMARKERS
7.4.VALIDATION BIOMARKERS
8.BIOMARKERS MARKET, BY APPLICATION
8.1. OVERVIEW
8.2. DIAGNOSTICS DEVELOPMENT
8.3. DRUG DISCOVERY AND DEVELOPMENT
8.4. PERSONALIZED MEDICINE
8.5 DISEASE-RISK ASSESSMENT
8.6. OTHERS
9.BIOMARKERS MARKET, BY INDICATION
9.1.OVERVIEW
9.2.CANCER
9.3.CARDIOVASCULAR DISORDERS
9.4.NEUROLOGICAL DISORDERS
9.5.IMMUNOLOGICAL DISORDERS
9.6.OTHER DISEASES
10.BIOMARKERS MARKET, BY GEOGRAPHY
10.1.COUNTRYWISE DRUG DELIVERY DEVICES MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
10.1.1.NORTH AMERICA
10.1.1.1.U.S.
10.1.1.2.CANADA
10.1.1.3.MEXICO
10.1.2.EUROPE
10.1.2.1.GERMANY
10.1.2.2.FRANCE
10.1.2.3.U.K.
10.1.2.4.ITALY
10.1.2.5.SPAIN
10.1.2.6.RUSSIA
10.1.2.7.TURKEY
10.1.2.8.BELGIUM
10.1.2.9.NETHERLANDS
10.1.2.10.SWITZERLAND
10.1.2.11.REST OF EUROPE
10.1.3.ASIA-PACIFIC (APAC)
10.1.3.1.JAPAN
10.1.3.2.CHINA
10.1.3.3.SOUTH KOREA
10.1.3.4.INDIA
10.1.3.5.AUSTRALIA
10.1.3.6.SINGAPORE
10.1.3.7.THAILAND
10.1.3.8.MALAYSIA
10.1.3.9.INDONESIA
10.1.3.10.PHILIPPINES
10.1.3.11.REST OF APAC
10.1.4.LATIN AMERICA
10.1.4.1.BRAZIL
10.1.4.2.REST OF LATIN AMERICA
10.1.5.MIDDLE EAST AND AFRICA
10.1.5.1.SOUTH AFRICA
10.1.5.2.REST OF MIDDLE EAST AND AFRICA
10.2.KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
11.BIOMARKERS MARKET: COMPETITIVE LANDSCAPE
11.1.GLOBAL BIOMARKERS MARKET: COMPANY SHARE ANALYSIS
11.2.U.S. BIOMARKERS MARKET: COMPANY SHARE ANALYSIS
11.3.EUROPE BIOMARKERS MARKET: COMPANY SHARE ANALYSIS
11.4.APAC BIOMARKERS MARKET: COMPANY SHARE ANALYSIS
11.5.SOUTH AMERICA BIOMARKERS MARKET: COMPANY SHARE ANALYSIS
11.6.MIDDLE EAST AND AFRICA BIOMARKERS MARKET: COMPANY SHARE ANALYSIS
11.7.MERGERS & ACQUISITIONS
11.8.NEW PRODUCT DEVELOPMENT & APPROVALS
11.9.EXPANSIONS
11.10.REGULATORY CHANGES
11.11.PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
12.BIOMARKERS MARKET, COMPANY PROFILES
12.1.QIAGEN N.V
12.1.1.COMPANY OVERVIEW
12.1.2.SWOT ANALYSIS
12.1.3.REVENUE ANALYSIS
12.1.4.PRODUCT PORTFOLIO
12.1.5.RECENT DEVELOPEMENTS
12.1.6.DATA BRIDGE ANALYSIS
12.2.PERKINELMER, INC
12.2.1.COMPANY OVERVIEW
12.2.2.SWOT ANALYSIS
12.2.3.REVENUE ANALYSIS
12.2.4.PRODUCT PORTFOLIO
12.2.5.RECENT DEVELOPEMENTS
12.2.6.DATA BRIDGE ANALYSIS
12.3.MERCK & CO, INC.
12.3.1.COMPANY OVERVIEW
12.3.2.SWOT ANALYSIS
12.3.3.REVENUE ANALYSIS
12.3.4.PRODUCT PORTFOLIO
12.3.5.RECENT DEVELOPEMENTS
12.3.6.DATA BRIDGE ANALYSIS
12.4.BIO-RAD LABORATORIES
12.4.1.COMPANY OVERVIEW
12.4.2.SWOT ANALYSIS
12.4.3.REVENUE ANALYSIS
12.4.4.PRODUCT PORTFOLIO
12.4.5.RECENT DEVELOPEMENTS
12.4.6.DATA BRIDGE ANALYSIS
12.5.ENZO BIOCHEM, INC.,
12.5.1.COMPANY OVERVIEW
12.5.2.SWOT ANALYSIS
12.5.3.REVENUE ANALYSIS
12.5.4.PRODUCT PORTFOLIO
12.5.5.RECENT DEVELOPEMENTS
12.5.6.DATA BRIDGE ANALYSIS
12.6.EKF DIAGNOSTICS HOLDINGS, PLC
12.6.1.COMPANY OVERVIEW
12.6.2.SWOT ANALYSIS
12.6.3.REVENUE ANALYSIS
12.6.4.PRODUCT PORTFOLIO
12.6.5.RECENT DEVELOPEMENTS
12.6.6.DATA BRIDGE ANALYSIS
12.7.MESO SCALE DIAGNOSTICS
12.7.1.COMPANY OVERVIEW
12.7.2.SWOT ANALYSIS
12.7.3.REVENUE ANALYSIS
12.7.4.PRODUCT PORTFOLIO
12.7.5.RECENT DEVELOPEMENTS
12.7.6.DATA BRIDGE ANALYSIS
12.8.LLC, SINGULEX, INC.,
12.8.1.COMPANY OVERVIEW
12.8.2.SWOT ANALYSIS
12.8.3.REVENUE ANALYSIS
12.8.4.PRODUCT PORTFOLIO
12.8.5.RECENT DEVELOPEMENTS
12.8.6.DATA BRIDGE ANALYSIS
12.9.CISBIO BIOASSAYS
12.9.1.COMPANY OVERVIEW
12.9.2.SWOT ANALYSIS
12.9.3.REVENUE ANALYSIS
12.9.4.PRODUCT PORTFOLIO
12.9.5.RECENT DEVELOPEMENTS
12.9.6.DATA BRIDGE ANALYSIS
12.10.BIOSIMS TECHNOLOGIES
12.10.1.COMPANY OVERVIEW
12.10.2.SWOT ANALYSIS
12.10.3.REVENUE ANALYSIS
12.10.4.PRODUCT PORTFOLIO
12.10.5.RECENT DEVELOPEMENTS
12.10.6.DATA BRIDGE ANALYSIS
12.11. SIGNOSIS, INC.
12.11.1.COMPANY OVERVIEW
12.11.2.SWOT ANALYSIS
12.11.3.REVENUE ANALYSIS
12.11.4.PRODUCT PORTFOLIO
12.11.5.RECENT DEVELOPEMENTS
12.11.6.DATA BRIDGE ANALYSIS
13.APPENDIX
14.ABOUT DATA BRIDGE MARKET RESEARCH

Other Report

Global Contraceptive Devices Market – Industry Trends and Forecast to 2024

Global Contraceptive Devices Market By product (Male contraceptive devices, Female contraceptive devices (Female Condoms, Intrauterine Devices) Contraceptive Sponges, Contraceptive Diaphragms, Contraceptive Patches, Sub-dermal Contraceptive Implants, Non-Surgical Permanent Contraceptive Devices, Contraceptive Vaginal Rings), by End-User (Hospitals, Ambulatory Surgical Centers, Clinics, Homecare), By Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024

Report Access: databridgemarketresearch.com/reports/global-contraceptive...

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sales@databridgemarketresearch.com
Investor: investors@databridgemarketresearch.com
Visit Blog databridgemarketresearch.com/blog/
Follow us on LinkedIn: www.linkedin.com/company/data-bridge-market-research

This release was published on openPR.
News-ID: 722793 • Views: 329
More releasesMore releases

You can edit or delete your press release here: